News
» Go to news main±«Óătv and Memorial University of Newfoundlandâled research team awarded CIHR grant for pharmacyâbased sexual health services project
Dr. Kyle Wilby, associate professor and associate director of program evaluation in the College of Pharmacy, is co-leading a much-needed and nationally-anticipated research project: Improving sexual health for Canadians through a pharmacy-based sexual health services model.
The research project has received a from the Canadian Institutes of Health Research (CIHR). The grant has a value of $1.9 million and will be distributed over a five-year period. Dr. (pictured left), professor in Memorial University of Newfoundlandâs School of Pharmacy, is Dr. Wilbyâs collaborator and the projectâs lead and principal applicant.
Ìę
âThe grant will be used to develop knowledge about how to scale, sustain, and pay for pharmacy-based sexual health services (PbSHS) model projects. Our project aims to understand the factors that go into sustaining research into practice, and to help provinces scale services up to a point where a patient could receive a full suite of sexual health services in pharmacies,â Dr. Wilby says.
The PbSHS model has been proven to reduce the strain on the primary health care system by increasing the range of pharmaciesâ service offerings. Moreover, it improves patient accessibility to sexual health services.
Dr. Wilby explains how individuals from vulnerable and underserved populations (2SLGBTQIA+, people who use drugs, racially diverse individuals, immigrants, refugees, and people with disabilities) are more likely to face barriers to sexual health care. Some potential barriers include not having access to a regular health care professional, and experiences of discrimination and stigma in communities and health care systems alike.
âIn my research within the 2SLGBTQIA+ population, weâve found that people have or have had, in the Maritime provinces in particular, negative experiences within health care settings where it doesnât make them really want to go and seek care, so they delay care, and/or they avoid care,â Dr. Wilby says.
The project aligns with Dr. Wilbyâs areas of research, which include 2SLGBTQIA+ health, program implementation and evaluation, health and cultural safety training for healthcare professionals, and more. His responsibilities as project co-lead include facilitating communication between different groups, leading research teams, conducting project recruitment, seeking stakeholder feedback, supervising graduate and PharmD students, and various other duties.
âOne of the key goals of this project is to build capacity and to help train students in research, and ±«Óătv students will definitely be getting involved,â Dr. Wilby says.
The project will be conducted in three phases. The first phase will consist of scalability assessments to determine provincesâ levels of preparedness for the PbSHS modelâs implementation. These assessments will include consultations with pharmacists, pharmacy support staff, stakeholders, and patients to determine how the model can be made more accessible, and which factors are essential for its success.
The projectâs second phase will consist of stakeholder consultations to revise the PbSHS modelâs implementation plans. The projectâs third phase will aim to increase public and stakeholder awareness of and increase capacity for the PbSHS modelâs implementation across the country.
Project background
The project is based on learnings from four in-progress PbSHS projects in Alberta, Newfoundland and Labrador, and Nova Scotia. Dr. Kelly initiated the first of these projects, entitled , back in 2017. The projectâs first phase monitored the introduction of Human Immunodeficiency Virus (HIV) testing in pharmacies across Newfoundland and Labrador and Alberta. The projectâs second phase (), which implemented HIV, Hepatitis C, and Syphilis testing in pharmacies across Newfoundland and Labrador, Alberta, and Nova Scotia, was launched on December 1, 2022: World AIDS (Acquired Immunodeficiency Syndrome) Day. This study is still actively recruiting people to be tested in pharmacies and more information can be found at the .
âI thought it was really innovative to have those services in pharmacies,â Dr. Wilby says.
Inspired by APPROACHâs innovative and successful framework, Dr. Wilby initiated the PrEP-Rx - Pharmacist Prescribing of Pre-Exposure Prophylaxis (PrEP) for HIV project in Nova Scotia in February 2023. In Alberta, two more PbSHS projects have also been launched for treatment of Hepatitis C and other sexually transmitted infections.
All four initial PbSHS projects have been receiving positive feedback from pharmacists, pharmacy support teams, and community members. The projectsâ pharmacists have reported that providing sexual health services offers them the opportunity to discuss the full scope of their professional capabilities with patients. Ultimately, the projects have been empowering patients to view their pharmacists as links with the greater health care system.
âPharmacy patients were saying: âI went to my pharmacist for PrEP prescribing, but I didnât know that they could prescribe for other things, or give me a vaccine, or refer me to a mental health professional,ââ Dr. Wilby says.
Recent News
- Dr. OmiSoore Drydenâs appointment to the School of Nursing
- How welcoming is Canada?
- STAFF SNAPSHOT: Andrew Pelrine, Manager of Alumni Engagement and Donor Relations
- Nursing students support local community in population health promotion project
- Bridging continents: Dal students to learn, share and connect in West Africa
- Partnership between UpLift and Public Health sees continued funding allocated for Youth Engagement Coordinators
- Dal Health grad students use podcasting to discover the people behind the science
- Nursing student closer to living out her dream of helping people thanks to support of new award